Section Arrow
VCEL.NASDAQ
- Vericel Corp
Quotes are at least 15-min delayed:2026/07/15 17:41 EDT
After Hours
Last
 46.72
0 (0.00%)
Bid
37.94
Ask
47.25
High 46.72 
Low 46.72 
Volume 7.79K 
Regular Hours (Closed)
Last
 46.72
+0.63 (+1.37%)
Day High 
47.365 
Prev. Close
46.09 
1-M High
48.325 
Volume 
318.93K 
Bid
37.94
Ask
47.25
Day Low
45.62 
Open
45.62 
1-M Low
37.21 
Market Cap 
2.35B 
Currency 美元 
P/E 107.19 
%Yield -- 
10-SMA 46.6 
20-SMA 43.94 
50-SMA 38.59 
52-W High 48.325 
52-W Low 28.95 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.43/0.82
Enterprise Value
2.44B
Balance Sheet
Book Value Per Share
6.98
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
--
Operating Revenue Per Share
3.63
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
VIVSVivoSim Lab Inc0.8529+0.0181+2.17%0.47PE
After Hours 0.8199 -0.033 -3.87%
LIMNLiminatus Pharma Inc0.1145+0.011+10.63%-- 
After Hours 0.1189 +0.0044 +3.84%
IOVAIovance Biotherapeutics4.74+0.81+20.61%-- 
After Hours 4.71 -0.03 -0.63%
ERNAErnexa Therapeutics Inc.6.73+0.67+11.06%0.01PE
After Hours 7.19 +0.46 +6.84%
PHIOPhio Pharmaceuticals Corp0.8901-0.1399-13.58%-- 
After Hours 0.9161 +0.026 +2.92%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.